Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study

International Journal of Cardiology

Volumn 164, Issue 2, 2013, Pages 221-226

  Oliveira, C P M S ^a   Kappel, C R ^b   Siqueira, E R ^c   Lima, V M R ^a   Stefano, J T ^a   Michalczuk, M T ^b   Marini, S S ^b   Barbeiro, H V ^a   Soriano, F G ^a   Carrilho, F J ^a   Pereira, L M M B ^c   Alvares Da Silva, M R ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Liver Institute of Pernambuco   (Brazil)

Author keywords

Cardiovascular risk; Framingham Score; Hepatitis C virus; Pro inflammatory cytokines

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE; ARTICLE; BODY MASS; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FRAMINGHAM RISK SCORE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; HYPERTENSION; LIVER BIOPSY; PATHOGENESIS;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84875217762     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.016     Document Type: Article

References (40)

1. M.J. Alter Epidemiology of hepatitis C in the West Semin Liver Dis 15 1995 5 14
2. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
3. L. Fartoux, A. Poujol-Robert, J. Guechot, D. Wendum, R. Poupon, and L. Serfaty Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C Gut 54 2005 1003 1008
4. S. Clément, S. Pascarella, and F. Negro Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress Viruses 1 2009 126 143
5. F. Negro, and S. Clément Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C J Viral Hepat 16 10 2009 681 688
6. G.H. Syed, Y. Amako, and A. Siddiqui Hepatitis C virus hijacks host lipid metabolism Trends Endocrinol Metab 21 1 2009 33 40
7. M.S. Freiberg, D.M. Cheng, K.L. Kraemer, R. Saitz, L.H. Kuller, and J.H. Samet The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals AIDS 21 2007 193 197
8. M. Fukui, Y. Kitagawa, N. Nakamura, and T. Yoshikawa Hepatitis C virus and atherosclerosis in patients with type 2 diabetes JAMA 289 2003 1245 1246
9. C. Vassalle, S. Masini, F. Bianchi, and G.C. Zucchelli Evidence for association between hepatitis C virus seropositivity and coronary artery disease Heart 90 2004 565 566
10. N. Ishizaka, Y. Ishizaka, and E. Takahashi Association between hepatitis C virus seropositivity, carotidartery plaque, and intima-media thickening Lancet 359 2002 133 135
11. M. Boddi, R. Abbate, and B. Chellini HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques Dig Liver Dis 39 Suppl 1 2007 S55 S60
12. P.M. Jacobson Brown, and M.G. Neuman Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines Clin Biochem 34 2001 167 171
13. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 1876 1890
14. Z. Abbas, and T. Moatter Interleukin (IL) 1b and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels JPMA 53 2 2003 59 62
15. G. Maggi, R. Bottelli, and D. Gola Serum cholesterol and chronic hepatitis C Ital J Gastroenterol 28 1996 436 440
16. D. Marzouk, J. Sass, and I. Bakr Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt Gut 56 2007 1105 1110
17. M. Floris-Moore, A.A. Howard, Y. Lo, E.E. Schoenbaum, J.H. Arnsten, and R.S. Klein Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men AIDS Patient Care STDS 21 2007 479 491
18. K.E. Corey, E. Kane, C. Munroe, L.L. Barlow, H. Zheng, and R.T. Chung Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up Hepatology 50 2009 1030 1037
19. J. Danesh, R. Collins, and R. Peto Chronic infections and coronary heart disease: is there a link? Lancet 350 1997 430 436
20. S.M. Gruady, B. Hansen, and S.C. Smith Jr. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung and Blood Institute/American Diabetes Association conference on scientific issues related to management Circulation 109 2004 551 567
21. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
22. C. Anderson Risk assessment. End of an era Nature 353 1991 289
23. J.I. Tsui, M.A. Whooley, A. Monto, K. Seal, P.C. Tien, and M. Shlipak Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study J Card Fail 15 5 2009 451 456
24. A. Mostafa, M.K. Mohamed, and M. Saeed Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors Gut 59 8 2010 1135 1140
25. L. Llorent, Y. Richaud-Patin, and N. Alcocer-Castillejos Cytokine gene expression in cirrhotic and non-cirrhotic human liver J Hepatol 24 1996 555 563
26. D.F. Fiorentino, A. Zlotnik, and P. Vieira IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 1991 3444 3451
27. F.Y. Yue, R. Dummer, and R. Geertsen Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class I, HLA class II and ICAM-1 molecules Int J Cancer 71 1997 630 637
28. T. Tsuruma, A. Yagihashi, and T. Torigoe Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras transformed cells Cell Immunol 184 1998 121 128
29. J.C. Zeller, A. Panoskaltsis-Mortari, and W.J. Murphy Induction of CD4 T cell alloantigen specific hyporesponsiveness by IL10 and TGF-b J Immunol 163 1999 3684 3691
30. R. de Waal Malefyt, J. Haanen, and H. Spits Interleukin 10 (IL10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression J Exp Med 174 1991 915 924
31. R. de Waal Malefyt, J. Abrams, and B. Bennett Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1991 1209 1220
32. A.M. Guiltinan, Z. Kaidarova, and B. Custer Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors Am J Epidemiol 167 2008 743 750
33. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 1876 1890
34. A. Lecube, C. Hernández, J. Genescà, and R. Simó Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study Diabetes Care 29 5 2006 1096 1101
35. J.M. Fernandez-Real, and W. Ricart Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness Diabetologia 42 1999 1367 1374
36. M. Persico, M. Capasso, and E. Persico Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy Hepatology 46 4 Oct 2007 1009 1015
37. K.L. Milner, D. van der Poorten, and M. Trenell Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance Gastroenterology 138 3 Mar 2010 932 941
38. X.Z. Ruan, J.F. Moorhead, R. Fernando, D.C. Wheeler, S.H. Powis, and Z. Varghese PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway J Am Soc Nephrol 14 2003 593 600
39. Y. Chen, X.Z. Ruan, and Q. Li Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells Am J Physiol Renal Physiol 293 2007 680 687
40. C. Wanner, V. Krane, and W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248